10x Genomics Inc. (TXG)
Market Closed
16 Oct, 08:00 PM
$
69. 86
-2.53
-3.495%
$
9.1B Market Cap
- P/E Ratio
- Div Yield
3.39M Volume
-2.12 Eps
$ 72.39
Previous Close 
Want to track TXG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
10x Genomics Inc. (TXG) Statistics
Valuation metrics
Market Cap 9.1B
Enterprise value 9.82B
Trailing P/E (ttm) -136.69
Forward P/E 118.4
PEG ratio 0.3
Price/Sales (ttm) 16.6
Price/Book (mrq) 12.7
Enterprise Value/Revenue 15.91
Enterprise Value/EBITDA 260.57
Overview
Shares outstanding 128.99M
Float 115.09M
Shares short 16.25M
% Held by insiders 0.02%
% Held by institutions 1.1%
Average volume (10 days) 3.69M
Average volume (90 days) 2.83M
Price summary
52-Week low 11.8
52-Week high 102.81
Beta 2.05
50-Day moving average 76.48
200-Day moving average 32.45
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:2
Last split Date 17 Jul 2006
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.12%
Operating margin -0.14%
Operational effectiveness
Return on assets -0.07%
Return on equity -0.09%
Income Statement
Revenue (ttm) 638.78M
Revenue per share (ttm) 4.75
Quarterly revenue growth (yoy) -0.03%
Gross profit (ttm) 445.11M
EBITDA -30.67M
Net income to common (ttm) -22.66M
Diluted EPS (ttm) -0.58
Quarterly earnings growth (yoy) -0.03%
Balance Sheet
Total cash (mrq) 539.85M
Total cash per share (mrq) 4.25
Total debt (mrq) 81.39M
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 5.69%
Book value per share (mrq) 6.35
Cash Flow
Cash flow statement 127.82M
Levered free cash flow (LFCF) 124.55M
2026 © Marketlog. All Rights Reserved.
